Identification of Celiac Ganglia
NCT01010360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-03-01
Summary
Computer-aided image recognition will improve the technique of endoscopic ultrasound-celiac plexus block/celiac plexus neurolysis (EUS-CPB/CPN) and improved pain relief.
Conditions
- Celiac Ganglia
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Julia LeBlanc, MD, MPH · Indiana University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- United States
Study Locations
More Related Trials
-
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
NCT04053452 ·Status: TERMINATED ·Phase: NA
-
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
NCT03952637 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
NCT05257733 ·Status: WITHDRAWN
-
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
NCT04208828 ·Status: RECRUITING
-
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
NCT04871035 ·Status: RECRUITING
-
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
NCT04356781 ·Status: COMPLETED
-
Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
NCT04927598 ·Status: COMPLETED
-
IVIG vs SCIG in CIDP
NCT05584631 ·Status: RECRUITING ·Phase: PHASE1
-
Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT02465359 ·Status: COMPLETED ·Phase: NA
-
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
NCT06742255 ·Status: NOT_YET_RECRUITING
-
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
NCT02892890 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Pozelimab
NCT05232110 ·Status: APPROVED_FOR_MARKETING
-
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
NCT06479863 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
NCT02582853 ·Status: UNKNOWN
-
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
NCT02115997 ·Status: COMPLETED ·Phase: PHASE4
-
Adult Autoimmune Myopathies (MAIA)
NCT04792931 ·Status: RECRUITING ·Phase: NA
-
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
NCT02774239 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004833 ·Status: TERMINATED ·Phase: NA
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
Eliglustat on Gaucher Disease Type IIIB
NCT03519646 ·Status: COMPLETED ·Phase: NA
-
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
NCT06381284 ·Status: COMPLETED
-
A Study of NGM282 in Patients With Primary Sclerosing Cholangitis
NCT02704364 ·Status: COMPLETED ·Phase: PHASE2
-
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
NCT06041451 ·Status: UNKNOWN ·Phase: PHASE4
-
Cause, Development, and Progression of Stiff-Person Syndrome
NCT00030940 ·Status: COMPLETED
-
Safety of Splenic Stimulation for RA
NCT04955899 ·Status: RECRUITING ·Phase: NA